RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform
Go back to RBC Capital Upgrades Cardiome Pharma (CRME) to Outperform| CARDIOME PHARMA (NASDAQ: CRME) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $9.21 | |||
| Open | $28.95 | 52 Week Low | $2.35 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $0.00 | |||
| Volume | 525 | |||||
